These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
661 related articles for article (PubMed ID: 29299749)
1. A novel gene signature based on five glioblastoma stem-like cell relevant genes predicts the survival of primary glioblastoma. Chai R; Zhang K; Wang K; Li G; Huang R; Zhao Z; Liu Y; Chen J J Cancer Res Clin Oncol; 2018 Mar; 144(3):439-447. PubMed ID: 29299749 [TBL] [Abstract][Full Text] [Related]
2. A three ion channel genes-based signature predicts prognosis of primary glioblastoma patients and reveals a chemotherapy sensitive subtype. Wang HY; Li JY; Liu X; Yan XY; Wang W; Wu F; Liang TY; Yang F; Hu HM; Mao HX; Liu YW; Zhang SZ Oncotarget; 2016 Nov; 7(46):74895-74903. PubMed ID: 27713134 [TBL] [Abstract][Full Text] [Related]
3. A 63 signature genes prediction system is effective for glioblastoma prognosis. Zhang Y; Xu J; Zhu X Int J Mol Med; 2018 Apr; 41(4):2070-2078. PubMed ID: 29393370 [TBL] [Abstract][Full Text] [Related]
4. A novel risk signature with 6 RNA binding proteins for prognosis prediction in patients with glioblastoma. Huang QR; Li JW; Pan XB Medicine (Baltimore); 2021 Dec; 100(48):e28065. PubMed ID: 35049227 [TBL] [Abstract][Full Text] [Related]
5. Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells. Stangeland B; Mughal AA; Grieg Z; Sandberg CJ; Joel M; Nygård S; Meling T; Murrell W; Vik Mo EO; Langmoen IA Oncotarget; 2015 Sep; 6(28):26192-215. PubMed ID: 26295306 [TBL] [Abstract][Full Text] [Related]
6. An eight-mRNA signature outperforms the lncRNA-based signature in predicting prognosis of patients with glioblastoma. Gong Z; Hong F; Wang H; Zhang X; Chen J BMC Med Genet; 2020 Mar; 21(1):56. PubMed ID: 32188434 [TBL] [Abstract][Full Text] [Related]
7. A Novel Glucose Metabolism-Related Gene Signature for Overall Survival Prediction in Patients with Glioblastoma. Zhang C; Wang M; Ji F; Peng Y; Wang B; Zhao J; Wu J; Zhao H Biomed Res Int; 2021; 2021():8872977. PubMed ID: 33553434 [TBL] [Abstract][Full Text] [Related]
8. Identification of a DNA Repair-Related Multigene Signature as a Novel Prognostic Predictor of Glioblastoma. Jin S; Qian Z; Liang T; Liang J; Yang F; Sun L; Li W; Qiu X; Zhang M World Neurosurg; 2018 Sep; 117():e34-e41. PubMed ID: 29807183 [TBL] [Abstract][Full Text] [Related]
9. A robust two-gene signature for glioblastoma survival prediction. Pan Y; Zhang JH; Zhao L; Guo JC; Wang S; Zhao Y; Tao S; Wang H; Zhu YB J Cell Biochem; 2020 Jul; 121(7):3593-3605. PubMed ID: 31960992 [TBL] [Abstract][Full Text] [Related]
10. Bioinformatic Profiling Identifies a Glucose-Related Risk Signature for the Malignancy of Glioma and the Survival of Patients. Zhao S; Cai J; Li J; Bao G; Li D; Li Y; Zhai X; Jiang C; Fan L Mol Neurobiol; 2017 Dec; 54(10):8203-8210. PubMed ID: 27900679 [TBL] [Abstract][Full Text] [Related]
11. Integrated analysis of 34 microarray datasets reveals CBX3 as a diagnostic and prognostic biomarker in glioblastoma. Wang S; Liu F; Wang Y; Fan W; Zhao H; Liu L; Cen C; Jiang X; Sun M; Han P J Transl Med; 2019 May; 17(1):179. PubMed ID: 31138312 [TBL] [Abstract][Full Text] [Related]
12. A 35-gene signature discriminates between rapidly- and slowly-progressing glioblastoma multiforme and predicts survival in known subtypes of the cancer. Fatai AA; Gamieldien J BMC Cancer; 2018 Apr; 18(1):377. PubMed ID: 29614978 [TBL] [Abstract][Full Text] [Related]
13. Machine learning revealed stemness features and a novel stemness-based classification with appealing implications in discriminating the prognosis, immunotherapy and temozolomide responses of 906 glioblastoma patients. Wang Z; Wang Y; Yang T; Xing H; Wang Y; Gao L; Guo X; Xing B; Wang Y; Ma W Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33839757 [TBL] [Abstract][Full Text] [Related]
14. Prognostic value and immune relevancy of a combined autophagy-, apoptosis- and necrosis-related gene signature in glioblastoma. Bi Y; Wu ZH; Cao F BMC Cancer; 2022 Mar; 22(1):233. PubMed ID: 35241019 [TBL] [Abstract][Full Text] [Related]
15. Systematic identification, development, and validation of prognostic biomarkers involving the tumor-immune microenvironment for glioblastoma. Zhao B; Wang Y; Wang Y; Chen W; Liu PH; Kong Z; Dai C; Wang Y; Ma W J Cell Physiol; 2021 Jan; 236(1):507-522. PubMed ID: 32572951 [TBL] [Abstract][Full Text] [Related]
16. Investigation of Genetic Determinants of Glioma Immune Phenotype by Integrative Immunogenomic Scale Analysis. Zhao B; Wang Y; Wang Y; Dai C; Wang Y; Ma W Front Immunol; 2021; 12():557994. PubMed ID: 34220791 [TBL] [Abstract][Full Text] [Related]
17. A glycolysis-based ten-gene signature correlates with the clinical outcome, molecular subtype and IDH1 mutation in glioblastoma. Chen C; Shi Y; Li Y; He ZC; Zhou K; Zhang XN; Yang KD; Wu JR; Kung HF; Ping YF; Bian XW J Genet Genomics; 2017 Nov; 44(11):519-530. PubMed ID: 29169920 [TBL] [Abstract][Full Text] [Related]
18. A signature based on survival-related genes identifies high-risk glioblastomas harboring immunosuppressive and aggressive ECM characteristics. Chen D; Chen D; Cao D; Hu J; Yao Y Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Apr; 43(4):368-382. PubMed ID: 29774872 [TBL] [Abstract][Full Text] [Related]
19. Genome-wide methylomic and transcriptomic analyses identify subtype-specific epigenetic signatures commonly dysregulated in glioma stem cells and glioblastoma. Pangeni RP; Zhang Z; Alvarez AA; Wan X; Sastry N; Lu S; Shi T; Huang T; Lei CX; James CD; Kessler JA; Brennan CW; Nakano I; Lu X; Hu B; Zhang W; Cheng SY Epigenetics; 2018; 13(4):432-448. PubMed ID: 29927689 [TBL] [Abstract][Full Text] [Related]
20. A 4-miRNA signature predicts the therapeutic outcome of glioblastoma. Niyazi M; Pitea A; Mittelbronn M; Steinbach J; Sticht C; Zehentmayr F; Piehlmaier D; Zitzelsberger H; Ganswindt U; Rödel C; Lauber K; Belka C; Unger K Oncotarget; 2016 Jul; 7(29):45764-45775. PubMed ID: 27302927 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]